Global Retinal Vein Occlusion Market Size By Type, By Treatment, By End-Users, By Geographic Scope And Forecast

Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Retinal Vein Occlusion Market Size And Forecast

Retinal Vein Occlusion Market size was valued at USD 12.17 Billion in 2023 and is projected to reach USD 21.96 Billion by 2030, growing at a CAGR of 8.7% during the forecast period 2024-2030.

The Retinal Vein Occlusion Market encompasses the pharmaceuticals, medical devices, and healthcare services aimed at the diagnosis, treatment, and management of retinal vein occlusion occurring as a medical emergency. Retinal vein occlusion is a severe condition characterized by the blockage of veins in the retina, leading to impaired blood flow, retinal hemorrhages, and vision loss. Emergency interventions are crucial to prevent irreversible damage to the retina and preserve visual acuity.

Global Retinal Vein Occlusion Market Drivers

The market drivers for the Retinal Vein Occlusion Market can be influenced by various factors. These may include

  • Growing Retinal Vein Occlusion (RVO) Incidence The main factor propelling the market is the increasing incidence of retinal vein occlusion, a common retinal vascular disease. The incidence of RVO is rising due to a number of factors, including an ageing population, diabetes, hypertension, and other cardiovascular disorders.
  • Improvements in Diagnostic Technologies Early and more precise detection of retinal vein occlusion is now possible thanks to advancements in diagnostic technologies such as fluorescein angiography and optical coherence tomography (OCT). For management and treatment to be effective, early diagnosis is essential.
  • Growing Ageing Population Retinal vein occlusion (RVO) is more common in the elderly, and as the world’s population ages, so does the frequency of age-related eye disorders.
  • Growing Conscience and Screening Initiatives Early diagnosis of retinal vein occlusion is facilitated by increased knowledge of the disorder and the availability of screening programmes. Serious vision loss and its repercussions can be avoided with early management.
  • Improvements in Treatment Options New and more efficient treatments for retinal vein occlusion are being developed as a result of ongoing research and development in the field of ophthalmology. This covers surgical procedures, laser treatments, and pharmaceutical therapy.
  • Development of Healthcare Infrastructure Patients with retinal vein occlusion will have easier access to eye care services, diagnosis, and treatment thanks to improvements in healthcare infrastructure, particularly in emerging nations.
  • Growing Healthcare Expenditure The Retinal Vein Occlusion Market may benefit from rising healthcare spending on a worldwide scale, which comes from both governments and private citizens. This covers spending on innovation, research, and the use of cutting-edge therapeutic alternatives.
  • Risk Factors for Retinal Vein Occlusion Diabetes and high blood pressure are two known risk factors for retinal vein occlusion. The incidence of RVO is expected to rise along with the global prevalence of these illnesses.
  • Regulatory Support and Approvals By giving patients additional alternatives and extending treatment options, regulatory approvals for novel medications and therapies for retinal vein occlusion support market expansion.
  • Patient Education Initiatives Increasing efforts to inform the public about the value of routine eye exams, particularly for those with risk factors, can lead to early diagnosis and treatment.

Global Retinal Vein Occlusion Market Restraints

Several factors can act as restraints or challenges for the Retinal Vein Occlusion Market. These may include

  • Restricted Treatment Options If retinal vein occlusion is discovered at an advanced stage, there may not be many options for treatment. When patients and healthcare providers look for more effective and varied treatment alternatives, this limitation may have an impact on the market’s growth.
  • Exorbitant Treatment Costs Anti-VEGF (vascular endothelial growth factor) medications and laser therapy can be expensive therapies for retinal vein occlusion. The expansion of the market may be impacted by certain patients’ limited access to these treatments due to concerns about affordability and reimbursement.
  • Difficulties with Diagnosis Effective care of retinal vein occlusion depends on a prompt and precise diagnosis. Difficulties with early diagnosis and identification could cause therapy to be delayed, which would hinder the market’s overall growth.
  • Adverse Effects of Treatments Intravitreal injections is one treatment for retinal vein blockage that may have risks and adverse effects. Potential side effects worries may affect patient acceptance and prevent some medications from being widely used.
  • Research and development (R&D) issues may arise in the pursuit of novel and enhanced therapeutics for retinal vein occlusion. This includes concerns about the condition’s intricacy, the unpredictability of science, and the time and expense required to introduce novel medicines to the market.
  • Regulatory Obstacles Getting new medications or medical devices approved by the government can be a drawn-out and challenging procedure. In the event that regulatory licences are not obtained in a timely manner, new and maybe more effective therapies may not be able to reach the market.
  • Patient Education and Awareness One potential barrier is a lack of knowledge of retinal vein occlusion and viable treatments among patients and healthcare professionals. To guarantee early discovery and suitable management, increased awareness and education initiatives are required.
  • Healthcare Infrastructure Access to state-of-the-art medical facilities and specialised eye care may be restricted in some areas. Market expansion may be impacted by the infrastructure and resource availability for retinal vein occlusion diagnosis and treatment.
  • Economic Factors Uncertainties or downturns in the economy might affect patient affordability and healthcare spending. The demand for retinal vein occlusion therapies may be impacted by economic variables.

Global Retinal Vein Occlusion Market Segmentation Analysis

The Global Retinal Vein Occlusion Market is Segmented on the basis of Type, Treatment, End-Users, And Geography.

Retinal Vein Occlusion Market, By Type

  • Branch Retinal Vein Occlusion (BRVO) Occlusion or blockage of one of the branches of the retinal vein.
  • Central Retinal Vein Occlusion (CRVO) Occlusion or blockage of the central retinal vein, affecting a larger area of the retina.

Retinal Vein Occlusion Market, By Treatment

  • Anti-VEGF (Vascular Endothelial Growth Factor) Therapy Injections of medications that inhibit the growth of abnormal blood vessels, commonly used in the treatment of macular edema associated with RVO.
  • Corticosteroids Intraocular injections or implants of corticosteroids to reduce inflammation and edema in the retina.
  • Laser Photocoagulation Laser treatment to seal or shrink abnormal blood vessels and reduce macular edema.
  • Vitrectomy Surgical procedure to remove blood or other fluids from the vitreous gel in the eye, which may be performed in severe cases.

Retinal Vein Occlusion Market, By End-Users

  • Hospitals and Clinics Diagnosis, treatment, and management of retinal vein occlusion may take place in hospitals and specialized clinics.
  • Ophthalmic Clinics Specialized eye care clinics focusing on the diagnosis and treatment of retinal diseases.
  • Ambulatory Surgical Centers (ASCs) Outpatient facilities that may provide surgical interventions for retinal vein occlusion.

Retinal Vein Occlusion Market, By Geography

  • North America Market conditions and demand in the United States, Canada, and Mexico.
  • Europe Analysis of the Retinal Vein Occlusion Market in European countries.
  • Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
  • Middle East and Africa Examining market dynamics in the Middle East and African regions.
  • Latin America Covering market trends and developments in countries across Latin America.

Key Players

The major players in the Retinal Vein Occlusion Market are

  • AbbVie
  • F. Hoffmann-La Roche AG
  • Regeneron Pharmaceuticals Inc.
  • Taiwan Liposome Company
  • Aerie Pharmaceuticals Inc.
  • Graybug Vision
  • Outlook Therapeutics
  • Kodiak Sciences Inc.
  • Chugai Pharmaceutical Co. Ltd.
  • Novartis AG
  • Bayer AG
  • Carl Zeiss AG
  • Annexin Pharmaceuticals AB (publ)

Report Scope

REPORT ATTRIBUTESDETAILS
STUDY PERIOD

2020-2030

BASE YEAR

2023

FORECAST PERIOD

2024-2030

HISTORICAL PERIOD

2020-2022

UNIT

Value (USD Billion)

KEY COMPANIES PROFILED

AbbVie, F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals Inc., Taiwan Liposome Company, Aerie Pharmaceuticals Inc., Outlook Therapeutics, Kodiak Sciences Inc., Chugai Pharmaceutical Co. Ltd.

SEGMENTS COVERED

By Type, By Treatment, By End-Users, And By Geography.

CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Conclusion

The market for emergency treatment of Retinal Vein Occlusion (RVO) is really taking off! We're seeing more and more cases of RVO, partly because people are living longer and lifestyle factors play a role. Better ways to diagnose the problem, like using optical coherence tomography (OCT) and fluorescein angiography, are helping. Plus, we're getting new drugs and devices that make treatment better. More and more, doctors are realizing how important it is to jump in quickly and are using less invasive surgeries, which is also helping the market grow. Because getting a fast diagnosis and taking care of RVO right away is becoming a priority, the Emergency RVO Market should see some serious growth in the years ahead.

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We dig deep into the market, looking at the numbers and the stories behind them, breaking it all down by economic and other factors. You'll get the market value (in USD Billion) for every piece of the pie. We'll also point out which areas and segments are likely to boom and become the biggest. Expect a geographic breakdown, showing where the product/service is being used and what's influencing the market in each place. We'll give you the competitive scene, including who's on top, what new stuff they're launching, who's teaming up, and who's buying who. Plus, you'll get detailed company profiles – think company overview, insights, benchmarking, and SWOT analysis – for the main players. Get a good look at where the market is now and where it's going, with all the latest trends, opportunities, and challenges in both new and established regions. We'll even break down the market using Porter's five forces and show you the value chain. Lastly, we will cover market dynamics and growth opportunities in the years ahead, and include 6 months of analyst support after purchase.

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.

Related Reports

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email